ANIP — ANI Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.67bn
- $1.90bn
- $883.37m
ANI Pharmaceuticals beats Q2 revenue, EPS beats estimates and raises FY forecast
ANI Pharmaceuticals Inc expected to post earnings of $1.42 a share - Earnings Preview
Brief: Cg Oncology Inc Delaware Superior Court Jury Issues Unanimous Verdict That Co Owes No Future Royalties Or Other Payments To Ani Pharmaceuticals
Brief: Ani Pharmaceuticals Announces Results From New Day Clinical Trial Of Iluvien® For Use In Patients With Diabetic Macular Edema (Dme)
U.S. STOCKS ON THE MOVE-Compass, Rumble, Tesla
U.S. STOCKS ON THE MOVE-HCI Group, Tesla, Kingstone
ANI Pharma rises after lifting 2025 forecasts
ANI Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: ANI Pharmaceuticals Announces The Launch Of Nitazoxanide Tablets
Brief: ANI Pharmaceuticals Announces Buyout Of Royalty Obligation For Iluvien And Yutiq
U.S. STOCKS ON THE MOVE-Washington Trust, Centessa Pharma, Kingstone
U.S. STOCKS ON THE MOVE-ANI Pharma, Ulta Beauty, KeyCorp
ANI Pharma rises on expanded US approval for eye-disease drug
U.S. STOCKS ON THE MOVE-HubSpot, Casey's General Stores, ANI Pharma
ANI Pharma rises after J.P.Morgan initiates coverage with 'overweight' rating
HubSpot rises after Barclays upgrades to 'overweight' on AI capabilities
Brief: ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe
U.S. STOCKS ON THE MOVE-BridgeBio Pharma, NetApp, Talen Energy
U.S. STOCKS ON THE MOVE-Recursion Pharmaceuticals, DoubleVerify Holdings, Praxis Precision Medicines